CWM
LLY icon

Chronos Wealth Management’s Eli Lilly LLY Stock Holding History

Chronos Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7M Sell
20,586
-341
-2% -$348K 10.96% 1
2026
Q1 		$19.2M Sell
20,927
-557
-3% -$565K 9.31% 1
2025
Q4 		$23.1M Sell
21,484
-475
-2% -$454K 10.69% 1
2025
Q3 		$16.8M Sell
21,959
-376
-2% -$280K 8.21% 1
2025
Q2 		$17.4M Buy
22,335
+550
+3% +$427K 9.02% 1
2025
Q1 		$18M Sell
21,785
-1,277
-6% -$1.06M 9.65% 1
2024
Q4 		$17.8M Sell
23,062
-158
-0.7% -$131K 9.09% 1
2024
Q3 		$20.6M Sell
23,220
-352
-1% -$316K 10.73% 1
2024
Q2 		$21.3M Sell
23,572
-626
-3% -$501K 11.86% 1
2024
Q1 		$18.8M Sell
24,198
-803
-3% -$571K 11.01% 1
2023
Q4 		$14.6M Sell
25,001
-1,918
-7% -$1.12M 9.27% 1
2023
Q3 		$14.5M Sell
26,919
-394
-1% -$203K 10.12% 1
2023
Q2 		$12.8M Sell
27,313
-927
-3% -$389K 8.86% 1
2023
Q1 		$9.7M Sell
28,240
-296
-1% -$99.8K 7.28% 3
2022
Q4 		$10.4M Sell
28,536
-1,183
-4% -$419K 8.24% 1
2022
Q3 		$9.61M Sell
29,719
-1,316
-4% -$417K 7.95% 1
2022
Q2 		$10.1M Sell
31,035
-5,636
-15% -$1.69M 7.54% 1
2022
Q1 		$10.5M Sell
36,671
-432
-1% -$111K 6.68% 3
2021
Q4 		$10.2M Sell
37,103
-225
-0.6% -$57K 6.21% 4
2021
Q3 		$8.63M Sell
37,328
-503
-1% -$124K 5.87% 5
2021
Q2 		$8.68M Buy
37,831
+390
+1% +$78.3K 5.96% 5
2021
Q1 		$7M Buy
37,441
+374
+1% +$73.2K 5.29% 6
2020
Q4 		$6.26M Buy
37,067
+376
+1% +$56.1K 5.13% 7
2020
Q3 		$5.43M Buy
36,691
+7,719
+27% +$1.19M 4.89% 7
2020
Q2 		$4.76M Buy
28,972
+4,588
+19% +$704K 4.6% 7
2020
Q1 		$3.38M Buy
24,384
+4,328
+22% +$595K 3.9% 12
2019
Q4 		$2.64M Buy
+20,056
New +$2.32M 2.59% 16

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Chronos Wealth Management's LLY Position: Q2 2026 in Review

Chronos Wealth Management reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $348K and leaving 20,586 shares worth $24.7M. The position accounts for 10.96% of the portfolio, ranked #1.

Chronos Wealth Management first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chronos Wealth Management held 20,586 shares of Eli Lilly worth $24.7M as of Q2 2026.
  • Chronos Wealth Management sold 341 Eli Lilly shares in Q2 2026, an estimated $348K.
  • Eli Lilly made up 10.96% of Chronos Wealth Management's portfolio in Q2 2026, its #1 holding.
  • Chronos Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chronos Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.